Hemagen Diagnostics, Inc. provides human and veterinary diagnostic services worldwide. The company develops, manufactures, and markets VIRGO, a human clinical diagnostic line of immunoassays for the diagnosis of autoimmune and infectious diseases, and acute phase proteins. Its proprietary test kits are used to aid in the diagnosis of certain autoimmune and infectious diseases. It also provides human diagnostics, such as universal IFA components; supplies, controls and calibrators, accessories, and H-rotors; reagents, electrodes, equipment; and specialty assays, including Chagas, acute phase proteins, and cytokines. In addition, the company offers veterinary diagnostic products, such as equipment, reagents, supplies, accessories, and electrodes in chemistry, hematology, and electrolyte areas. Its products are used in laboratories, hospitals and blood banks. Hemagen Diagnostics, Inc. was incorporated in 1985 and is based in Columbia, Maryland.
0 transactions — 0 buys and 0 sales reported by Hemagen Diagnostics, Inc. executives.
0 institutional funds report a position on HMGN in their latest SEC quarterly filing.
Beyond raw data, we aggregate and score every smart money signal to give you a unique view.
8-dimension composite score: insiders · hedge funds · politicians · momentum · valuation · health · analysts · earnings.
Detection of clustered purchases or sales by several executives in the same stock.
Berkshire, Pershing Square, Tiger Global, Bridgewater and other reporting funds.
NANC & GOP (Pelosi & Republicans), GURU (top hedge funds), ARK (Cathie Wood). See who enters and exits each week.
Spot marked changes in search interest around the stocks being followed.
Create your watchlist and receive a brief of events affecting your tickers.
This public page only shows a preview. The full analysis of HMGN on the Kairos Insider dashboard includes:
Free signup · Pro €19/month or €190/year